Bertone Alicia L, Reisbig Nathalie A, Kilborne Allison H, Kaido Mari, Salmanzadeh Navid, Lovasz Rebecca, Sizemore Joy L, Scheuermann Logan, Kopp Rosalind J, Zekas Lisa J, Brokken Matthew T
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University , Columbus, OH , USA.
Front Vet Sci. 2017 Mar 10;4:31. doi: 10.3389/fvets.2017.00031. eCollection 2017.
To assess if injection of allogeneic dental pulp tissue particles would improve lameness in horses with naturally occurring osteoarthritis (OA) or soft tissue (ST) injury.
Prospective, randomized, blinded, and controlled clinical trial and client survey assessment.
Forty lame client-owned horses.
Sterile dental pulp, recovered from otherwise healthy foals that perish during dystocia, was processed under good manufacturing processing to produce mechanically manipulated, unexpanded pulp tissue particles containing viable cells surrounded in extracellular matrix. Forty lame client-owned horses with confirmed OA ( = 20), or ST injury (desmitis or tendonitis) received a 2 mL intra-articular ( = 20 OA) or intra-lesional ( = 20) injection of control transport vehicle ( = 20) or 10 × 10 dental pulp tissue particles ( = 20). Acclimatized horses had baseline measurements performed and were then injected on day 0. Horses were treadmill exercised for 2 weeks, evaluated by clinical parameters, lameness score, edema (score and circumference), pain on flexion (OA) or pressure (ST), and clients' scores for pain and discomfort before and through 45 days after pulp injection. Twenty horses were available for >2.5-year follow-up.
Pulp-treated horses showed decrease in lameness compared to baseline ( < 0.009) or placebo controls ( < 0.013) for at least 2 weeks. Client assessments of comfort were improved between before and 45 days after pulp injection ( < 0.001). Clinical improvement with ST injury was significantly greater than OA ( < 0.001). At >2.5-year follow-up, at least 10 horses were in work.
Dental pulp tissue particles can be considered as a treatment option for equine lameness due to OA, desmitis, or tendonitis.
评估注射同种异体牙髓组织颗粒是否能改善患有自然发生的骨关节炎(OA)或软组织(ST)损伤的马匹的跛行状况。
前瞻性、随机、双盲和对照临床试验及客户调查评估。
40匹跛行的客户拥有的马匹。
从难产时死亡的健康幼驹中回收无菌牙髓,按照良好生产规范进行处理,以生产机械处理的、未扩增的牙髓组织颗粒,其含有包裹在细胞外基质中的活细胞。40匹确诊为OA(n = 20)或ST损伤(腱炎或肌腱炎)的跛行客户拥有的马匹,接受2 mL关节内注射(n = 20 OA)或病灶内注射(n = 20),注射的是对照运输载体(n = 20)或10×10牙髓组织颗粒(n = 20)。适应环境后的马匹进行基线测量,然后在第0天进行注射。马匹在跑步机上运动2周,通过临床参数、跛行评分、水肿(评分和周长)、屈曲时疼痛(OA)或按压时疼痛(ST)以及客户对牙髓注射前和注射后45天内疼痛和不适的评分进行评估。20匹马可进行超过2.5年的随访。
与基线相比(P < 0.009)或与安慰剂对照组相比(P < 0.013),接受牙髓治疗的马匹至少在2周内跛行状况有所改善。客户对舒适度的评估在牙髓注射前和注射后45天之间有所改善(P < 0.001)。ST损伤的临床改善明显大于OA(P < 0.001)。在超过2.5年的随访中,至少有10匹马仍在工作。
牙髓组织颗粒可被视为治疗因OA、腱炎或肌腱炎导致的马跛行的一种治疗选择。